💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch
Profile for Aldeyra Therapeutics, Inc. (ALDX)
« Back to company indexALDX Chatter Timeline
Stock Ticker for ALDX
Most Active Tweeters for ALDX
| User | Tweets |
|---|---|
| @Tickeron | 7 |
| @TonyFauci2 | 6 |
| @FlashAlert_me | 4 |
| @MarcJacksonLA | 4 |
| @StockNewsBot2 | 3 |
Recent Tweets for ALDX
 |
@TonyFauci2 @GZuckerman @bradloncar Edelman was largest $ALDX backer May 26th 2022, 6:05pm |
 |
@ChartMill $ALDX was analyzed by 16 analysts. The buy consensus is at 88%. So analysts seem to be very confident about $ALDX.… https://t.co/95z6MaeqFH May 26th 2022, 4:05pm |
|
@TonyFauci2 @brendan_49 NOT arguing -just perplexed ? $ALDX claims better technology supports redness endpoint- no? https://t.co/jF1zyeS2Cx May 26th 2022, 3:05pm |
|
@TonyFauci2 @brendan_49 Changing primary endpoints late in a trial never seems to be a harbinger of positive results - that’s what $ALDX just did. Why? May 25th 2022, 8:05pm |
|
@TonyFauci2 $ALDX changed Primary Tranquilty 2 endpoint Again “The primary endpoint of the upcoming P3 TRANQUILITY-2 Trial has… https://t.co/RPd3hk0Pcg May 25th 2022, 6:05am |
 |
@MaisaCorp $ALDX Aldeyra Therapeutics Designates Schirmer Test As Sole Primary Endpoint In Phase 3 Tranquility-2 Trial Of Reproxalap In Dry Eye Disease May 24th 2022, 9:05pm |
 |
@Tickeron $ALDX in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/r44fnWZG72 May 24th 2022, 7:05pm |
|
@Tickeron How do you think the market will react to this? $ALDX Aroon Indicator entered a Downtrend. #AldeyraTherapeutics… https://t.co/ogg1NyAoSV May 24th 2022, 6:05pm |
 |
@MarcJacksonLA $ALDX Berenberg Bank Initiates Coverage On Aldeyra Therapeutics With A Buy Rating, $28 PT https://t.co/xKruSlBFiq May 24th 2022, 6:05pm |
 |
@Quantumup1 @MattBiotech I'm sticking with this $ALDX tweet And How did Zhang keep from cracking up from this video you tweet… https://t.co/m7QrDglVxV May 24th 2022, 4:05pm |
 |
@firebutworking RT @MattBiotech: History of $ALDX primary sign: - Reduction of RASP and we inhibit RASP, easy peasy - Hm, this might be harder to measure a… May 24th 2022, 4:05pm |
 |
@MattBiotech History of $ALDX primary sign: - Reduction of RASP and we inhibit RASP, easy peasy - Hm, this might be harder to me… https://t.co/INWbhVeSqv May 24th 2022, 4:05pm |
|
@TonyFauci2 @brendan_49 My point is - in Tranquilty $ALDX did a clinical assessment of redness - as all practitioners who may u… https://t.co/cyjxAedzkA May 24th 2022, 2:05pm |
|
@MarcJacksonLA $ALDX Aldeyra Therapeutics Designates Schirmer Test as Sole Primary Endpoint in Phase 3 TRANQUILITY-2 Trial of Repr… https://t.co/lzg5DyMLoz May 24th 2022, 1:05pm |
 |
@ItsTurk73 $ALDX https://t.co/cobCr3ruru May 24th 2022, 1:05pm |
 |
@otcdynamics $ALDX Aldeyra Therapeutics Designates Schirmer Test as Sole Primary Endpoint in Phase 3 TRANQUILITY-2 Trial of Repr… https://t.co/VbSn5YtKzd May 24th 2022, 11:05am |
 |
@UCSCTweetBot RT @stock_titan: $ALDX Aldeyra Therapeutics Designates Schirmer Test as Sole Primary Endpoint in Phase 3 TRANQUILITY-2 Trial of Reproxalap… May 24th 2022, 11:05am |
 |
@FlashAlert_me $ALDX [15s. delayed]: Issued Press Release on May 24, 07:00:00: Aldeyra Therapeutics Designates Schirmer Test as So… https://t.co/bIxaTsIdIb May 24th 2022, 11:05am |
 |
@investor_feed $ALDX 8-K Aldeyra Therapeutics (24 May, 7:05am) ? Other Events; Financial Statements and Exhibits… https://t.co/85gCWeRsUv May 24th 2022, 11:05am |
|
@FlashAlert_me $ALDX [15s. delayed] filed form 8-K on May 24, 07:05:43 https://t.co/GTCw7J8xHx May 24th 2022, 11:05am |
 |
@Market_Newswire $ALDX SEC Filing: 8-K Other Events - Aldeyra Therapeutics, Inc. (0001341235) May 24 https://t.co/KXh1Z1zXIM May 24th 2022, 11:05am |
 |
@bkfViking123 RT @BioStocks: $ALDX Designates Schirmer Test as Sole Primary Endpoint in Phase 3 TRANQUILITY-2 Trial of Reproxalap in Dry Eye Disease. To… May 24th 2022, 11:05am |
 |
@BioStocks $ALDX Designates Schirmer Test as Sole Primary Endpoint in Phase 3 TRANQUILITY-2 Trial of Reproxalap in Dry Eye Dis… https://t.co/Azgu3WpoAO May 24th 2022, 11:05am |
|
@firebutworking $ALDX Therapeutics Designates Schirmer Test as Sole Primary Endpoint in Phase 3 TRANQUILITY-2 Trial of Reproxalap in Dry Eye Disease May 24th 2022, 11:05am |
 |
@StockNewsBot2 $ALDX Aldeyra Therapeutics Designates Schirmer Test as Sole Primary Endpoint in Phase 3 TRANQUILITY-2 Trial of Repr… https://t.co/lxRcJQqzfr May 24th 2022, 11:05am |
|
@UCSCTweetBot RT @FastestAlert: $ALDX Aldeyra Therapeutics Designates Schirmer Test As Sole Primary Endpoint In Phase 3 TRANQUILITY-2 Trial Of Reproxalap… May 24th 2022, 11:05am |
 |
@FastestAlert $ALDX Aldeyra Therapeutics Designates Schirmer Test As Sole Primary Endpoint In Phase 3 TRANQUILITY-2 Trial Of Repr… https://t.co/SmO1gqw8oP May 24th 2022, 11:05am |
 |
@stock_titan $ALDX Aldeyra Therapeutics Designates Schirmer Test as Sole Primary Endpoint in Phase 3 TRANQUILITY-2 Trial of Repr… https://t.co/qAJXMP9LaY May 24th 2022, 11:05am |
 |
@WebChronicleTo1 $ALDX Aldeyra Therapeutics Designates Schirmer Test as Sole Primary Endpoint in Phase 3 TRANQUILITY-2 Trial of Repr… https://t.co/8UtMmS64gZ May 24th 2022, 11:05am |
 |
@1stOncology #AldeyraTherapeutics to Present at H.C. Wainwright Global #InvestmentConference $ALDX https://t.co/ZyaaTda72S May 24th 2022, 7:05am |
 |
@quant_alert $aldx Earnings reports today before the markets open.. https://t.co/BZqdgc4iXB May 24th 2022, 2:05am |
|
@Tickeron $ALDX's Aroon indicator drops into Downtrend on May 20, 2022. View odds for this and other indicators:… https://t.co/DEAbh5dUU1 May 23rd 2022, 11:05pm |
 |
@newsfilterio Aldeyra Therapeutics to Present at H.C. Wainwright Global Investment Conference $ALDX https://t.co/Ny2PYF0YGO May 23rd 2022, 10:05pm |
 |
@MC_OptionTrades $ALDX 17-Jun-22 Straddle Implies a ±27.3% move. May 24 H.C. Wainwright Global Investment Conference https://t.co/gWaapsJb9W May 23rd 2022, 9:05pm |
|
@otcdynamics $ALDX Aldeyra Therapeutics to Present at H.C. Wainwright Global Investment Conference https://t.co/pA40ePVsRR May 23rd 2022, 8:05pm |
|
@FlashAlert_me $ALDX [15s. delayed]: Issued Press Release on May 23, 16:05:00: Aldeyra Therapeutics to Present at H.C. Wainwright… https://t.co/Mtqo1Qe93X May 23rd 2022, 8:05pm |
|
@StockNewsBot2 $ALDX Aldeyra Therapeutics to Present at H.C. Wainwright Global Investment Conference https://t.co/EPbltuIFoV May 23rd 2022, 8:05pm |
|
@FastestAlert $ALDX Aldeyra Therapeutics To Present At H.C. Wainwright Global Investment Conference Stock News Alerts In Bio May 23rd 2022, 8:05pm |
|
@WebChronicleTo1 $ALDX Aldeyra Therapeutics to Present at H.C. Wainwright Global Investment Conference https://t.co/EhvKOlRu60 May 23rd 2022, 8:05pm |
|
@stock_titan $ALDX Aldeyra Therapeutics to Present at H.C. Wainwright Global Investment Conference https://t.co/CCh4McwQRw May 23rd 2022, 8:05pm |
 |
@bthefirsttoknow First out// $ALDX: Aldeyra Therapeutics to Present at H.C. Wainwright Global Investment Conference https://t.co/8c56PI4s3p May 23rd 2022, 8:05pm |
 |
@OwenMar54200817 $ALDX Top Analyst price target today https://t.co/2izrP1g81o May 23rd 2022, 6:05pm |
|
@TonyFauci2 Why Bother? $ALDX - Embarrassing https://t.co/1jJhIGmLYm May 23rd 2022, 5:05pm |
 |
@Geary_Enoch $ALDX For a limited time we are opening our trading chatroom for public,,,,, https://t.co/hl8yIRno89 May 21st 2022, 12:05pm |
 |
@AlertTrade REVERSALtoUP: $ALDX Aldeyra Therapeutics, Inc. ? TradeIdeas via ? https://t.co/VS8RO1bzXJ May 20th 2022, 3:05pm |
 |
@stock_patterns $ALDX - Pattern Detected ? Green line shows the recent price movements Red lines shows the similar price movements https://t.co/u9RiWUdLCx May 20th 2022, 2:05pm |
|
@Tickeron $ALDX's Aroon indicator drops into Downtrend on May 18, 2022. View odds for this and other indicators:… https://t.co/TuOGJJRuTN May 19th 2022, 7:05pm |
|
@MarcJacksonLA $ALDX Aldeyra's Dry Eye Candidate Tops Vehicle In Post-Hoc Analysis Using Computer Automated Grading In Ocular Redn… https://t.co/u6UPRnku89 May 18th 2022, 10:05pm |
 |
@Gambiste1 RT @AnthemTrading: $ALDX (2.46) Post-hoc analysis just more evidence this next trial will likely be successful. May 18th 2022, 9:05pm |
 |
@AnthemTrading $ALDX (2.46) Post-hoc analysis just more evidence this next trial will likely be successful. May 18th 2022, 9:05pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.